Details of the Drug Pharmacogenomic Perturbation Atlas
General Information of Drug (ID: DMFK8Y9)
| Drug Name | ||||||
|---|---|---|---|---|---|---|
| Synonyms |
Sodium dehydrocholate; 145-41-5; DEHYDROCHOLATE SODIUM; Dehydrocholate (sodium); Biliron; Carachol; Dehydrocholic acid sodium salt; UNII-W4193719XR; Suprachol; Biliton; Dycholium; Dilabil sodium; Decholin Sodium; Decholin sodium salt; W4193719XR; Natriumdehydrocholat [German]; Dehydrocholic acid, sodium salt; Sodium 3,7,12-triketocholanate; Natrii dehydrocholas [INN-Latin]; Dehidrocolato sodico [INN-Spanish]; EINECS 205-652-1; 81-23-2 (Parent); Dehydrocholate de sodium [INN-French]; Natriumdehydrocholat; Sodium 3,7,12-trioxo-5-bet
| |||||
| Cross-matching ID | ||||||
Consensus Signature of Drug Pharmacogenomic Perturbation (DPP)
|
|
||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
Pharmacogenomic Perturbation Across Diseases and Tissues
|
Breast
Breast adenocarcinoma
Colon
Colorectal adenocarcinoma
Kidney
Normal (Immortalized)
Liver
Hepatoblastoma
Lung
Lung adenocarcinoma
Non-small cell lung carcinoma
Prostate
Prostate carcinoma
Skin
Melanoma
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
